← FDA Drug Approvals (Drugs@FDA)
LEVOCARNITINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2025-06-30
Drug application
- FDA Application #
ANDA217430- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOCARNITINE
- Generic name
- LEVOCARNITINE
- Active ingredients
- LEVOCARNITINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- DEVA HOLDING AS
- Manufacturer
- Devatis Inc.
- First approval
- 2025-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown